content

Batavia and KU Leuven join forces to accelerate development of highly promising COVID-19 vaccine candidate

KU Leuven, a leading research institution and one of the top 50 universities in the world and Batavia Biosciences, a contract development and manufacturing...

ViGeneron and WuXi AppTec Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy

ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), announced a strategic...

Ufovax extends IP portfolio to include patent covering the design of an optimized antigen for COVID-19

Ufovax, a vaccine biotechnology company, has extended its intellectual property portfolio to include an exclusive global license to a patent covering the design of...

BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years

BD, a leading global medical technology company, announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity...

New destinations for life-saving pharmaceutical products

DoKaSch Temperature Solutions and Air Europa have signed a Master Rental Agreement about the usage of the temperature-controlled Opticooler packaging solution. The collaboration opens...

UK Approves Pfizer COVID-19 Vaccine: Expect A Next Week Roll-Out

In a historic occurrence which has taken the world by storm, the UK Government has officially approved the usage of Pfizerโ€™s coronavirus vaccine. This...

Biopharma Market Worth $546.6 billion by 2027

Biopharma market was valued at approximately USD 244.1 Billion in 2019 and is expected to generate revenue of around USD 546.6 Billion by end...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read